Sublingual immunotherapy for allergy-related asthma

Immunotherapy using sublingual tablets containing house dust mite allergen extended the interval until patients developed a moderate asthma exacerbation in a manufacturer-sponsored clinical trial...
Source: Family Practice News - Category: Primary Care Source Type: news